308 related articles for article (PubMed ID: 31011885)
21. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
22. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
23. The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis.
Melnikov M; Rogovskii V; Boyko A; Pashenkov M
Mult Scler Relat Disord; 2018 Apr; 21():19-23. PubMed ID: 29454152
[TBL] [Abstract][Full Text] [Related]
24. Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors.
Robichon K; Sondhauss S; Jordan TW; Keyzers RA; Connor B; La Flamme AC
Sci Rep; 2021 Feb; 11(1):2966. PubMed ID: 33536582
[TBL] [Abstract][Full Text] [Related]
25. Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Chen SJ; Huang SH; Chen JW; Wang KC; Yang YR; Liu PF; Lin GJ; Sytwu HK
Int Immunopharmacol; 2016 Feb; 31():169-77. PubMed ID: 26735612
[TBL] [Abstract][Full Text] [Related]
26. Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis.
Hofstetter H; Gold R; Hartung HP
Int MS J; 2009 Apr; 16(1):12-8. PubMed ID: 19413921
[TBL] [Abstract][Full Text] [Related]
27. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
28. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
29. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Takada I; Yogiashi Y; Makishima M
Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
[TBL] [Abstract][Full Text] [Related]
30. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
31. The Role of D
Melnikov M; Sviridova A; Rogovskii V; Kudrin V; Murugin V; Boyko A; Pashenkov M
Curr Neuropharmacol; 2022; 20(8):1632-1639. PubMed ID: 34429055
[TBL] [Abstract][Full Text] [Related]
32. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
33. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
34. Betaine Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Dendritic Cell-Derived IL-6 Production and Th17 Differentiation.
Yang C; Lai W; Zhou J; Zheng X; Cai Y; Yang W; Xie S; Gao Y; Du C
J Immunol; 2018 Feb; 200(4):1316-1324. PubMed ID: 29330324
[TBL] [Abstract][Full Text] [Related]
35. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
36. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
37. Contribution of LTi and T
Schropp V; Rohde J; Rovituso DM; Jabari S; Bharti R; Kuerten S
J Neuroinflammation; 2019 May; 16(1):111. PubMed ID: 31138214
[TBL] [Abstract][Full Text] [Related]
38. Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
Seki SM; Stevenson M; Rosen AM; Arandjelovic S; Gemta L; Bullock TNJ; Gaultier A
J Immunol; 2017 Jun; 198(12):4607-4617. PubMed ID: 28507026
[TBL] [Abstract][Full Text] [Related]
39. The role of dopamine in the modulation of monocyte-induced Th17- and Th1-immune response in multiple sclerosis.
Belousova O; Lopatina A; Melnikov M
Int Immunopharmacol; 2024 Jun; 137():112540. PubMed ID: 38908080
[TBL] [Abstract][Full Text] [Related]
40. [Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis].
Melnikov MV; Sviridova AA; Solodova TV; Lopatina AV; Pashenkov MV; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):82-89. PubMed ID: 34387452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
